Drug Safety

Understanding and Communicating Key Concepts in Risk Management: What do we Mean by Benefit and Risk?
pp. 449-452(4)
Authors: Edwards, I. Ralph; Lindquist, Marie

Potential Risks Associated with the Use of Herbal Anti-Obesity Products
pp. 453-456(4)
Author: Chan, Thomas Y.K.

Treatment of Chronic Non-Malignant Pain in the Elderly: Safety Considerations
pp. 457-474(18)
Authors: >Jonathan Bruce Barber,; Gibson, Stephen J.

Behavioural Adverse Effects of Dopaminergic Treatments in Parkinson's Disease: Incidence, Neurobiological Basis, Management and Prevention
pp. 475-488(14)
Authors: Antonini, Angelo; Cilia, Roberto

NSAIDs and the Risk of Accidental Falls in the Elderly: A Systematic Review
pp. 489-498(10)
Authors: Hegeman, Judith; >Bart J.F. van den Bemt,; Duysens, Jacques; >Jacques van Limbeek,

Safety and Drug Utilization Profile of Varenicline as Used in General Practice in England: Interim Results from a Prescription-Event Monitoring Study
pp. 499-507(9)
Authors: Kasliwal, Rachna; Wilton, Lynda V.; Shakir, Saad A.W.

An Evaluation of Three Signal-Detection Algorithms Using a Highly Inclusive Reference Event Database
pp. 509-525(17)
Authors: Hochberg, Alan M.; Hauben, Manfred; Pearson, Ronald K.; O'Hara, Donald J.; Reisinger, Stephanie J.; Goldsmith, David I.; Gould, A. Lawrence; Madigan, David

Topical Corticosteroids and the Risk of Diabetes Mellitus: A Nested Case-Control Study in the Netherlands
pp. 527-537(11)
Authors: >Michiel W. van der Linden,; Beest, Fernie J.A. Penning-van; Nijsten, Tamar; Herings, Ron M.C.